Acasti Pharma Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.36 | -$0.36 | -$0.36 |
| Q2 2024 | 1 | -$0.54 | -$0.54 | -$0.54 |
| Q3 2024 | 1 | -$0.51 | -$0.51 | -$0.51 |
| Q1 2025 | 1 | -$0.46 | -$0.46 | -$0.46 |
| Q2 2025 | 1 | -$0.35 | -$0.35 | -$0.35 |
| Q3 2025 | 1 | -$0.41 | -$0.41 | -$0.41 |
| Q4 2025 | 1 | -$0.49 | -$0.49 | -$0.49 |
| Q1 2026 | 1 | -$0.46 | -$0.46 | -$0.46 |
Acasti Pharma Inc. Earnings Date And Information
Acasti Pharma Inc. last posted its earnings results on Friday, August 9th, 2024. The company reported $-0.24 earnings per share for the quarter, topping analysts' consensus estimates of $-0.28 by $0.04. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Acasti Pharma Inc. has generated $-1 earnings per share over the last year ($-1.35 diluted earnings per share) and currently has a price-to-earnings ratio of -3.1. Acasti Pharma Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Sunday, November 10th, 2024 based on prior year's report dates.
Acasti Pharma Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/09/2024 | Q1 2024 | -$0.28 | -$0.24 | 0.04 | $0 | $0 |
| 06/21/2024 | Q4 2023 | -$0.35 | -$0.34 | 0.01 | $0 | |
| 02/12/2024 | Q3 2023 | -$0.30 | -$0.21 | 0.09 | $0 | |
| 11/13/2023 | Q2 2023 | -$0.29 | -$0.49 | -0.2 | $0 | |
| 08/11/2023 | Q1 2023 | -$0.63 | -$0.54 | 0.09 | $0 | |
| 06/23/2023 | Q4 2022 | -$3.91 | $-32,000 | |||
| 02/14/2023 | Q3 2022 | -$0.78 | -$0.52 | 0.26 | $0 | |
| 11/14/2022 | Q2 2022 | -$0.66 | $0 | |||
| 08/11/2022 | Q1 2022 | -$0.61 | $0 | |||
| 06/21/2022 | Q4 2021 | -$0.54 | $0 | |||
| 02/14/2022 | Q3 2021 | -$0.48 | -$0.51 | -0.03 | $0 | |
| 11/10/2021 | Q2 2021 | $0.18 | $0 | |||
| 08/12/2021 | Q1 2021 | -$0.72 | $0 | |||
| 06/22/2021 | Q4 2020 | -$1.30 | $115,000 | |||
| 02/09/2021 | Q3 2020 | -$1.54 | $81,000 | |||
| 11/16/2020 | Q2 2020 | -$3.36 | -$3.10 | 0.26 | $0 | |
| 08/13/2020 | Q1 2020 | -$3.36 | -$2.47 | 0.89 | $0 | |
| 06/29/2020 | Q4 2019 | $10.08 | $0 | |||
| 12/31/2019 | Q3 2019 | -$6.66 | $0 | |||
| 11/13/2019 | Q2 2019 | -$3.84 | -$12.37 | -8.53 | $0 |
Acasti Pharma Inc. Earnings: Frequently Asked Questions
-
When is Acasti Pharma Inc.'s earnings date?
Acasti Pharma Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Sunday, November 10th, 2024 based off last year's report dates.
-
Did Acasti Pharma Inc. beat their earnings estimates last quarter?
In the previous quarter, Acasti Pharma Inc. (:ACST) reported $-0.24 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.28 by $0.04.
-
How can I listen to Acasti Pharma Inc.'s earnings conference call?
The conference call for Acasti Pharma Inc.'s latest earnings report can be listened to online.
-
How can I read Acasti Pharma Inc.'s conference call transcript?
The conference call transcript for Acasti Pharma Inc.'s latest earnings report can be read online.
-
How much profit does Acasti Pharma Inc. generate each year?
Acasti Pharma Inc. (:ACST) has a recorded net income of $0. Acasti Pharma Inc. has generated $-1.35 earnings per share over the last four quarters.
-
What is Acasti Pharma Inc.'s price-to-earnings ratio?
Acasti Pharma Inc. (:ACST) has a price-to-earnings ratio of -3.1 and price/earnings-to-growth ratio is -0.16.
